ClinicalTrials.gg
RecruitingNCT07511751MPS-TREATUpdated May 7, 2026

COMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME

An interventional study of Dry Needling and Extracorporeal Shock Wave Therapy in Myofascial Pain Syndrome, sponsored by ALİEMAN. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by ALİEMAN · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Myofascial Pain Syndromes with a site in Turkey — 12 open to participants now, 12 under way, none of them phase 3. Myofascial Pain Syndromes · Turkey.

Planned enrollment
24th of 67
60 · median 60
Started
2026
with 7 others
No phase
62 of 81
8 open now
Primary completion
2027-03
later than 9 of 11 live
Registered
70th of 81
by date

Among the 81 studies in Myofascial Pain Syndromes with a site in Turkey, this one is the 24th largest by planned enrollment of the 67 interventional ones that give a count, is one of 8 that started in 2026, is one of 62 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 70th registered.

Myofascial Pain Syndromes

340 studies on the registry are indexed under Myofascial Pain Syndromes; 67 are open to participants now.

Browse Myofascial Pain Syndromes studies →

Open to participants now

12 of the 81 studies in Myofascial Pain Syndromes with a site in Turkey are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 35 Myofascial Pain Syndromes studies recruiting now, 6 (17%) set no upper age limit and 26 (74%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Myofascial Pain Syndromes with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to compare the effectiveness of dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) in patients with chronic musculoskeletal pain. The primary outcomes include pain intensity and functional status. Patients will be randomly assigned to different treatment groups, and outcomes will be evaluated before and after the interventions. The results of this study are expected to contribute to determining the most effective treatment method for pain management.

Read the detailed description

Myofascial pain syndrome is a common musculoskeletal disorder characterized by trigger points and chronic pain. Various treatment modalities such as dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) are used in clinical practice; however, there is no clear consensus on the most effective approach.

This randomized, parallel-group study aims to compare the effectiveness of these three treatment methods in patients diagnosed with myofascial pain syndrome. Eligible patients aged between 18 and 65 years with chronic back pain lasting at least 3 months will be included in the study. Participants will be randomly assigned to receive dry needling, ESWT, or PRF treatment.

Pain intensity will be assessed using the Numeric Rating Scale (NRS), and functional outcomes will also be evaluated. The study is expected to contribute to the current literature by providing comparative data on these commonly used treatment modalities and guiding clinical decision-making.

03

Conditions studied

  • Myofascial Pain Syndrome

Keywords

  • myofascial pain syndrome
  • dry needling
  • ESWT
  • pulsed radiofrequency
  • pain
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years
  • Clinically diagnosed myofascial pain syndrome
  • Back pain lasting at least 3 months
  • Failure to respond to conservative treatments

Exclusion criteria

Exclusion Criteria:

  • History of cervical surgery or cervical disc pathology
  • Fibromyalgia
  • Shoulder pathologies
  • Coagulation disorders or use of anticoagulant therapy
  • Infection, , or inflammatory spinal diseases
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Dry Needling Group

    Patients receiving dry needling treatment.

    Procedure: Dry Needling

  • Experimental
    ESWT Group

    Patients receiving extracorporeal shock wave therapy (ESWT)

    Procedure: Extracorporeal Shock Wave Therapy

  • Experimental
    PRF Group

    Patients receiving pulsed radiofrequency (PRF) treatment.

    Procedure: Pulsed radiofrequency(PRF)

Interventions

  • ProcedureDry Needling

    Dry needling applied to myofascial trigger points

  • ProcedureExtracorporeal Shock Wave Therapy

    Extracorporeal shock wave therapy applied to the painful area

  • ProcedurePulsed radiofrequency(PRF)

    Pulsed radiofrequency applied to the target area for the treatment of myofascial pain syndrome

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using the Numeric Rating Scale(NRS). Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.

    Time frame: Baseline, 1 month, and 3 months after treatment

Secondary outcomes

  1. Pressure Pain Threshold

    Pressure pain threshold will be measured using algometry. Pressure pain threshold will be measured using an algometer (kg/cm²). Higher values indicate lower pain sensitivity and improved clinical condition.

    Time frame: Baseline, 1 month, and 3 months after treatment

  2. Neck Disability Index (NDI)

    Functional status will be evaluated using the Neck Disability Index (NDI). Functional status will be assessed using the Neck Disability Index (NDI), with scores ranging from 0 to 50. Higher scores indicate greater functional impairment.

    Time frame: Baseline, 1 month, and 3 months after treatment

  3. Quality of Life (SF-12

    Quality of life will be assessed using the Short Form-12 (SF-12) questionnaire. The SF-12 includes physical and mental component summary scores, with higher scores indicating better health-related quality of life.

    Time frame: Baseline, 1 month, and 3 months after treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.

Of 203 non-industry interventional studies with no phase under Myofascial Pain Syndromes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 13. This study's planned 12 months is above that.

Counting every sponsor, half of 205 studies reached it within 5 months; a quarter within 2 and three quarters within 13.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 6, 2026
StartActual
Mar 10, 2026
Primary completionEst.
Mar 10, 2027
CompletionEst.
Mar 10, 2027
Last update
May 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07511751
Lead sponsor
ALİEMAN
Responsible party
ALİEMAN (Associate Professor, Department of Anesthesiology and Reanimation, Sakarya University) — Sponsor-investigator
First posted
Apr 6, 2026
Start date
Mar 10, 2026
Primary completion
Mar 10, 2027 (estimated)
Completion
Mar 10, 2027 (estimated)
Last update
May 7, 2026

Study contacts

AYSENUR IMAMOGLU BABA, MD,Resident
Contact
aysenurimamoglub@gmail.com
+905437866097
KEMAL NAS, MD, Professor
principal investigator · Sakarya University Training and Research Hospital, Department of Algology
RIDVAN ISIK, MD
study chair · Sakarya University Training and Research Hospital, Department of Algology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion